Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC).
Purity:
>98.0%
CAS Number:
[1031360-18-5]
Target:
S1P Receptor
* VAT and and shipping costs not included. Errors and price changes excepted